Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$81
|
$229B |
3.5x |
8.2x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$188B |
3.0x |
7.7x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€83
|
$135B |
2.5x |
8.5x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$96.7B |
2.2x |
6.5x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 243
|
$87.7B |
5.6x |
16.8x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€169
|
$39.3B |
5.2x |
19.0x |
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 61
|
$10.2B |
N/A |
N/A |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$110
|
$10.1B |
3.7x |
-7.2x |
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 20
|
$8.2B |
2.6x |
21.4x |
Alk-Abello
|
Denmark |
Vaccines & Immunotherapies
|
DKK 190
|
$6.7B |
7.2x |
25.9x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$30
|
$6.6B |
2.5x |
-1.7x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 3286
|
$6.2B |
13.8x |
43.8x |
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 85
|
$5.6B |
14.8x |
88.4x |
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 16
|
$3.7B |
5.7x |
14.3x |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$2.9B |
50.8x |
N/A |
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$33
|
$2.7B |
N/A |
N/A |
Everest Medicines
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
HKD 67
|
$2.6B |
17.0x |
-35.3x |
AstraZeneca India
|
India |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
INR 9091
|
$2.6B |
N/A |
N/A |
BioKangtai
|
China |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
CNY 15
|
$2.6B |
6.4x |
24.9x |
SK Bioscience
|
South Korea |
Vaccines & Immunotherapies
|
KRW 48750
|
$2.2B |
6.9x |
-77.6x |
Walvax Biotechnology
|
China |
Vaccines & Immunotherapies
|
CNY 11
|
$2.1B |
5.2x |
23.0x |
Bavarian Nordic
|
Denmark |
Vaccines & Immunotherapies
|
DKK 173
|
$1.9B |
2.0x |
6.9x |
GC Biopharma
|
South Korea |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
KRW 16287
|
$1.5B |
N/A |
N/A |
Immunocore Holdings
|
Germany |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€28
|
$1.3B |
N/A |
N/A |
Changchun BCHT
|
China |
Vaccines & Immunotherapies
|
CNY 21
|
$1.2B |
6.7x |
23.7x |
Hualan Biological Vaccine
|
China |
Vaccines & Immunotherapies
|
CNY 17
|
$1.1B |
5.6x |
8.3x |
Jinyu Bio-Technology Co.
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 8
|
$1.1B |
6.0x |
22.9x |
Chengdu Kanghua
|
China |
Vaccines & Immunotherapies
|
CNY 64
|
$1.1B |
5.2x |
13.3x |
Keqian Biology
|
China |
Vaccines & Immunotherapies
|
CNY 16
|
$865M |
6.0x |
11.9x |
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$858M |
2.8x |
24.9x |
Cidara Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$49
|
$855M |
1367.7x |
N/A |
CStone Pharmaceuticals
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 5
|
$853M |
19.2x |
-37.1x |
Celldex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$791M |
150.2x |
-3.6x |
AIM Vaccine
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 4
|
$771M |
4.1x |
N/A |
Liaoning Chengda Biotech
|
China |
Vaccines & Immunotherapies
|
CNY 26
|
$766M |
3.1x |
10.2x |
CureVac
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$5
|
$749M |
2.2x |
13.8x |
HBM Holdings
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 8
|
$743M |
7.0x |
9.3x |
Shanghai Hile Bio-Tech
|
China |
Vaccines & Immunotherapies
|
CNY 8
|
$629M |
N/A |
N/A |
Novavax
|
United States of America |
Vaccines & Immunotherapies
|
$7
|
$599M |
0.7x |
5.4x |
Renata
|
Bangladesh |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BDT 488
|
$597M |
1.7x |
10.2x |
Valneva
|
France |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
€2
|
$565M |
2.7x |
-217.7x |
Luzhu Biotech
|
Hong Kong |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
HKD 24
|
$558M |
407.8x |
-27.1x |
Allergy Therapuetics
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$552M |
6.9x |
-23.2x |
Recbio
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 8
|
$551M |
N/A |
-9.3x |
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$457M |
69.2x |
-1.8x |
GlaxoSmithKline Pakistan
|
Pakistan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
PKR 399
|
$427M |
1.9x |
N/A |
Northwest Biotherapeutics
|
United States of America |
Vaccines & Immunotherapies
|
$0
|
$423M |
N/A |
N/A |
Medigen Vaccine Biologics
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 41
|
$413M |
18.3x |
96.8x |
Kamada
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 26
|
$378M |
2.1x |
9.6x |
AnaptysBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$24
|
$373M |
4.4x |
-3.4x |
Faron Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£2
|
$347M |
357547.6x |
-14.3x |
CytomX Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$322M |
2.7x |
20.8x |
Replimune Group
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$317M |
21.1x |
-1.1x |
Coherus Oncology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$281M |
1.8x |
-2.6x |
Compass Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$278M |
650.3x |
N/A |
Ocugen
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Genomics & Personalized Medicine
|
$1
|
$273M |
83.6x |
N/A |
Ourofino
|
Brazil |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BRL 23
|
$272M |
1.4x |
6.4x |
Corvus Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$262M |
662.3x |
N/A |
Adimmune
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 17
|
$260M |
N/A |
N/A |
Tevogen Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$240M |
N/A |
N/A |
Agenus
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$240M |
2.1x |
N/A |
CHO Pharma
|
Taiwan |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
TWD 40
|
$215M |
N/A |
N/A |
Nektar Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$189M |
2.8x |
-1.6x |
Candel Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$174M |
N/A |
-5.5x |
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$173M |
86.9x |
-1.5x |
Autolus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$2
|
$172M |
5.1x |
-0.8x |
Instil Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$27
|
$163M |
N/A |
N/A |
Scancell
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$147M |
26.3x |
-8.4x |
Vaxcell-Bio
|
South Korea |
Vaccines & Immunotherapies
|
KRW 9740
|
$143M |
N/A |
N/A |
Greenwich LifeSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$131M |
N/A |
N/A |
Turk İlaç
|
Turkey |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TRY 21
|
$126M |
N/A |
N/A |
Cartesian Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$125M |
6.0x |
N/A |
OSE Immunotherapeutics
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€5
|
$123M |
1.7x |
3.7x |
Acepodia
|
Taiwan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TWD 16
|
$119M |
N/A |
N/A |
Celularity
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine,
Vaccines & Immunotherapies
|
$2
|
$116M |
N/A |
N/A |
Elicio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$114M |
N/A |
N/A |
Transgene
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€1
|
$109M |
4.8x |
-5.2x |
Anixa Biosciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$88.7M |
N/A |
N/A |
Genelux
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$79.1M |
20170.6x |
-3.4x |
Atara Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$77.2M |
0.6x |
11.0x |
Immatics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$73.9M |
0.6x |
-0.8x |
Vaxart
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$72.3M |
2.9x |
N/A |
Coya Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$64.2M |
15.1x |
N/A |
LakeShore Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$63.5M |
N/A |
N/A |
IO Biotech
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$62.8M |
N/A |
-0.7x |
Allogene Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$61.5M |
4092.9x |
-0.3x |
Eledon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$60.4M |
N/A |
N/A |
Immix Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$56.2M |
N/A |
-2.6x |
Compugen
|
Israel |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 6
|
$55.8M |
2.4x |
N/A |
Adaptimmune Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$55.4M |
0.5x |
-0.7x |
INmune Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$49.9M |
1364.4x |
N/A |
Cue Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$46.4M |
5.3x |
N/A |
Cabaletta Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$43.6M |
19.5x |
-0.3x |
Vir Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$42.3M |
0.9x |
-0.1x |
European Medical
|
Belgium |
Vaccines & Immunotherapies
|
€5
|
$41.7M |
N/A |
N/A |
Invivyd
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$41.0M |
0.6x |
-0.4x |
PDS Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$39.8M |
N/A |
-1.0x |
Medicenna Therapeutics
|
Canada |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CAD 1
|
$34.3M |
404.2x |
N/A |
MiNK Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$30.7M |
N/A |
N/A |
AC Immune
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$30.7M |
1.8x |
N/A |